The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 19 , ISSUE 2 ( February, 2018 ) > List of Articles

ORIGINAL RESEARCH

Antifungal Activity of Xylitol against Candida albicans: An in vitro Study

Zahra Talattof, Azita Azad, Maryam Zahed, Nazanin Shahradnia

Citation Information : Talattof Z, Azad A, Zahed M, Shahradnia N. Antifungal Activity of Xylitol against Candida albicans: An in vitro Study. J Contemp Dent Pract 2018; 19 (2):125-129.

DOI: 10.5005/jp-journals-10024-2225

License: CC BY 3.0

Published Online: 01-08-2012

Copyright Statement:  Copyright © 2018; The Author(s).


Abstract

Aim

The most common fungal infection among human population is candidiasis, the etiology of which is mostly Candida albicans. As a result of a disrupted balance of the normal flora or a compromised immune system, Candida species can become pathogenic. Various in vitro surveys have shown that glucose intake is a promoter of C. albicans growth, whereas in vivo studies have found that xylitol can decrease the risk of candidiasis and angular cheilitis. Hence, we aimed to evaluate for the first time the inhibitory effects of xylitol on C. albicans by assessing its minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC).

Materials and methods

The standard strain of C. albicans was acquired. The fungi were incubated in supplemented brain—heart infusion broth for 48 hours at 37°C. The MIC was measured according to the Clinical and Laboratory Standards Institute (CLSI) M100-S24 standard. Microdilution method was applied using 360-μL sterilized polystyrene flat-bottomed 96-well plates. The antimicrobial effects were examined by the microbroth dilution method according to the CLSI M100-S24 standard.

Results

The MIC of xylitol for C. albicans was found to be 20 × 104 μg/mL. Furthermore, the concentration of 40 × 104 μg/mL with a decrease of 99.95% in the colony-forming units (CFUs) of the microorganism was found to be the MFC of xylitol for C. albicans.

Conclusion

According to the results of this survey, xylitol has considerable antimicrobial effects. Hence, this substance can be used as an effective element in gums, toothpastes, and antimicrobial mouthwashes, especially in patients with candidiasis.

Clinical significance

By knowing the MIC and MFC of xylitol, this substance can be effectively used in products aimed to cure this fungal infection.

How to cite this article

Talattof Z, Azad A, Zahed M, Shahradnia N. Antifungal Activity of Xylitol against Candida albicans: An in vitro Study. J Contemp Dent Pract 2018;19(2):125-129.


HTML PDF Share
  1. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007 Jan;20(1):133-163.
  2. Growth of Candida albicans hyphae. Nat Rev Microbiol 2011 Aug;9(10):737-748.
  3. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013 Jan;62(Pt 1):10-24.
  4. Candida albicans, a major human fungal pathogen. J Microbiol 2011 Apr;49(2):171-177.
  5. Oral candidiasis and angular cheilitis. Dermatol Ther 2010 May-Jun;23(3):230-242.
  6. Denture stomatitis and Candida albicans in Iranian population: a systematic review and meta-analysis. J Dent (Shiraz) 2016 Sep;17(3 Suppl):283-292.
  7. Evaluating the etiologies of burning mouth symptom in patients of shiraz dental school from 2007 to 2015. Iran Red Crescent Med J 2017 Apr;19(4):e42675.
  8. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis 2009 Mar;48(5):503-535.
  9. Effect of dietary carbohydrates on the in vitro epithelial adhesion of Candida albicans, Candida tropicalis, and Candida krusei. Microbiol 2000 Jan;23(1):63-71.
  10. Dietary carbohydrates modulate Candida albicans biofilm development on the denture surface. PLoS One 2013 May;8(5):e64645.
  11. Modulating effect of dietry carbohydrate supplementation on Candida-albicans colonization and invasion in a neutropenic mouse model. Infect Immun 1993 Feb;61(2):619-626.
  12. The enhancement effect of three sugar alcohols on the fungicidal effect of benzethonium chloride toward Candida albicans. J Dent 2008 Nov;36(11):965-968.
  13. Levorotatory carbohydrates and xylitol subdue Streptococcus mutans and Candida albicans adhesion and biofilm formation. J Basic Microbiol 2016 May;56(5):480-492.
  14. Xylitol inhibits carcinogenic acetaldehyde production by Candida species. Int J Cancer 2011;129(8):2038-2041.
  15. Xylitol: a review on bioproduction, application, health benefits, and related safety issues. Crit Rev Food Sci Nutr 2015;55(11):1514-1528.
  16. Effect of xylitol versus sorbitol: a quantitative systematic review of clinical trials. Int Dent J 2012 Aug;62(4):175-188.
  17. Xylitol biological production: a review of recent studies. Food Rev Int 2015;31(1):74-89.
  18. Effect of xylitol on the growth of three oral strains of Candida albicans. J Dent Res 1975 Nov-Dec;54(6):1239.
  19. Effect of xylitol with various concentration and duration on the growth of Candida albicans (in vitro study). J Dent Indones 2009;16(1):72-76.
  20. The in vitro iysozyme susceptibility of Candida albicans cultured in carbohydrate supplemented media. Oral Microbiol Immunol 1993 Jun;8(3):177-181.
  21. The influence of dietary carbohydrates on in vitro adherence of four Candida species to human buccal epithelial cells. Microb Ecol Health Dis 2005 Jul;17(3):156-62.
  22. Evaluation of antimicrobial effectiveness of C-8 xylitol monoester as an alternative preservative for cosmetic products. Int J Cosmet Sci 2011 Oct;33(5):391-397.
  23. The effects of xylitol and sorbitol on lysozyme-and peroxidase-related enzymatic and candidacidal activities. Arch Oral Biol 2015 Jul;60(7):998-1006.
  24. Antimicrobial evaluation of new metallic complexes with xylitol active against P. aeruginosa and C. albicans: MIC determination, post-agent effect and ZN-uptake. J Inorg Biochem 2016 Feb;155:67-75.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.